AAAAAA

   
Results: 1-10 |
Results: 10

Authors: LEOTSAKOU C BALTATHAKIS I KARAKASIS D HARHALAKIS N SKANDALI A NIKIFORAKIS E
Citation: C. Leotsakou et al., QUALITY-OF-LIFE IN SURVIVORS AFTER ALLO-BMT, Bone marrow transplantation, 21, 1998, pp. 547-547

Authors: KAKKAS I KARMIRIS T MALEKOU S BALTATHAKIS I GIGANTES S GIANNAKAKIS A PAGONIS M KARAKASIS D SKANDALIS A HARHALAKIS N NIKIFORAKIS E
Citation: I. Kakkas et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE (HD), Bone marrow transplantation, 21, 1998, pp. 571-571

Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL, Experimental hematology, 25(8), 1997, pp. 35-35

Authors: BAKIRI M MALECOU S GIANNAKAKI A KAPSIMALI V KOKKINIS H ECONOMIDOU I NIKIFORAKIS E
Citation: M. Bakiri et al., CHRONIC T-LARGE GRANULAR LYMPHOCYTOSIS - MOLECULAR STUDY AND CLINICALCOURSE, Blood, 90(10), 1997, pp. 2953-2953

Authors: GIGANTES S DELIMPASI S MALEKOU S PAGONI M KARAKASIS D KARMIRIS TH BAKIRI M MITSOULI C SKANDALIS A HARHALAKIS N NIKIFORAKIS E
Citation: S. Gigantes et al., 4 CYCLES OF CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA AGED OVER 50 YEARS, Blood, 90(10), 1997, pp. 3824-3824

Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 2654-2654

Authors: BOURANTAS K MITSULISMENTSIKOFF C TSIARA S FAKITSA B GALANAKIS E CHRISTOU L NIKIFORAKIS E
Citation: K. Bourantas et al., FOLLOW-UP OF 50 PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL), Journal of experimental & clinical cancer research, 14(3), 1995, pp. 307-312

Authors: SKANDALIS A MALEKOU S POULAKIDAS E TSIONOS K KAKKAS J KATOPI D KARMIRIS T KARAKASIS D HARHALAKIS N NIKIFORAKIS E
Citation: A. Skandalis et al., BUSULFAN (BU), CYCLOPHOSPHAMIDE (CY) AND ETOPOSIDE (VP-16) AS A PREPARATIVE REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3855-3855

Authors: APOSTOLIDIS J HARHALAKIS N SKANDALIS A KATOPI D SAKELLARIOU K KARAKASIS D KARMIRIS T NIKIFORAKIS E
Citation: J. Apostolidis et al., TRANSPLANT-RELATED MORTALITY (TRM) - THE EXPERIENCE OF A NEW BONE-MARROW TRANSPLANT UNIT, Blood, 84(10), 1994, pp. 10000703-10000703

Authors: LAZANAS MC TSEKES GA PAPANDREOU S HARHALAKIS N SCANDALI A NIKIFORAKIS E SAROGLOU G
Citation: Mc. Lazanas et al., LIPOSOMAL AMPHOTERICIN-B FOR LEISHMANIASIS TREATMENT OF AIDS PATIENTSUNRESPONSIVE TO ANTIMONIUM COMPOUNDS, AIDS, 7(7), 1993, pp. 1018-1019
Risultati: 1-10 |